This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at email@example.com or call + 1 (702) 988 2320.
Personalized cancer medicine is based on research into human genes and cancer genes. These investigations have aided in the development of more effective treatments. They’ve also used genetic data to build cancer diagnostics and prevention methods. Every year, cancer takes the lives of millions of people. Standard treatments, such as chemotherapy or radiation, are only effective in a small percentage of patients because of disease heterogeneity. Tumors can have a variety of genetic origins and may express various proteins in different patients. Other methods of cancer treatment may have more side effects than personalized cancer medicine. This is due to the fact that it is intended to be more particular. A tailored treatment may have fewer side effects on healthy cells and more on cancer cells.